CG
AMRI

Cutler Group’s Albany Molecular Research Inc AMRI Stock Holding History

Cutler Group’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,300
Closed -$21.3K – 7786
2016
Q4 		$24K Buy
+1,300
New +$22.1K ﹤0.01% 3304
2016
Q3 		– Sell
-800
Closed -$11.9K – 7846
2016
Q2 		$10K Buy
800
+200
+33% +$2.92K ﹤0.01% 4218
2016
Q1 		$9K Buy
+600
New +$9.4K ﹤0.01% 4248

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Cutler Group's AMRI Position: Q1 2017 in Review

Cutler Group sold out of Albany Molecular Research Inc (AMRI) in Q1 2017, closing a stake of 1,300 shares — an estimated $21.3K sold.

Cutler Group first reported a position in AMRI in Q1 2016 and held it in 3 quarters. The position peaked at $24K in Q4 2016. 139 funds tracked by Wall St. Rank hold AMRI as of Q1 2017.

  • Cutler Group reported no remaining Albany Molecular Research Inc position as of Q1 2017 after selling out during the quarter.
  • Cutler Group sold 1,300 Albany Molecular Research Inc shares in Q1 2017, an estimated $21.3K.
  • Cutler Group first reported a position in Albany Molecular Research Inc in Q1 2016 and held it in 3 quarters.
  • Cutler Group's Albany Molecular Research Inc position peaked at $24K in Q4 2016.
  • 139 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q1 2017.

Based on Cutler Group's 13F filing for Q1 2017, filed 11 Apr 2017.